ConductScience.org, home

Paper19252334

Mechanistic basis of using body size and maturation to predict clearance in humans.

Anderson BJ and 1 other. Drug Metab Pharmacokinet, 2009. Cited by 431 papers, by iCite.

Cite this record

ConductScience Library. Mechanistic basis of using body size and maturation to predict clearance in humans. Papers, record 19252334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19252334

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanistic basis of using body size and maturation to predict clearance in humans.
PubMed
Journal
Drug Metab Pharmacokinet
PubMed
Year
2009
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
431
iCite
Relative citation ratio, by iCite
15.8
iCite
Revised in PubMed
2022-03-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anderson BJBrian J
2Holford NHNick H G

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgingMajor topic
Body SizeMajor topic
Pharmaceutical PreparationsMajor topic
Acetaminophen
Animals
Body Surface Area
Glomerular Filtration Rate
Humans
Kidney
Liver
Metabolic Detoxication, Phase I
Metabolic Detoxication, Phase II
Models, Biological
Morphine
Predictive Value of Tests

Source PubMed

Download CSV of topics

Cited by279

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 431 citations.

PMIDTitleJournalYearIn PapersSource
42814651
Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35).
JMIR Res Protoc2026https://conductscience.org/library/papers/42814651PubMed
42678337Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections.J Clin Pharmacol2026https://conductscience.org/library/papers/42678337PubMed
42627441Model-Informed Precision Dosing in Pediatric Patients: Current Software Tools and Bedside Guided Application.Paediatr Drugs2026https://conductscience.org/library/papers/42627441PubMed
42515770Advancing Pediatric Dose Scaling: Strategies, Modeling Approaches, and Clinical Applications.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515770PubMed
42515693Population Pharmacokinetic Analysis and Modelling of Serum Uric Acid Dynamics in Patients Treated with Favipiravir.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515693PubMed
42509527
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.
Clin Pharmacokinet2026https://conductscience.org/library/papers/42509527PubMed
42471329A dynamic pharmacometric framework defining the relationship between ivermectin exposure and mosquito lethality.Sci Rep2026https://conductscience.org/library/papers/42471329PubMed
42387116Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling.Pharm Res2026https://conductscience.org/library/papers/42387116PubMed
42385200Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study.Br J Clin Pharmacol2026https://conductscience.org/library/papers/42385200PubMed
42377866Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review.Clin Pharmacokinet2026https://conductscience.org/library/papers/42377866PubMed
42244880Developmental age and clinical illness drive in vivo variability of CYP1A2 ontogeny and caffeine metabolism in preterm neonates.Front Pharmacol2026https://conductscience.org/library/papers/42244880PubMed
42198273Pharmacokinetics of Monoclonal Antibodies in Pediatrics: Model-Based Investigation on Allometric Scaling Exponents.Pharmaceutics2026https://conductscience.org/library/papers/42198273PubMed
41983018Albumin and Other Plasma Proteins in Pediatric Patients: What, When, and How Much They Influence Antimicrobial Pharmacology.J Pediatr Pharmacol Ther2026https://conductscience.org/library/papers/41983018PubMed
41869741Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir-ritonavir in patients with COVID-19.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41869741PubMed
41665863Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis.Clin Pharmacokinet2026https://conductscience.org/library/papers/41665863PubMed
41536035Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41536035PubMed
41499525PET/CT imaging of tuberculosis lung lesions in marmosets treated with different drug regimens aligns with human clinical outcomes.Sci Transl Med2026https://conductscience.org/library/papers/41499525PubMed
41471106Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy.Pharmaceutics2025https://conductscience.org/library/papers/41471106PubMed
41348398Pharmacokinetics and Target Attainment of Fluoroquinolones in Older Adults: A Systematic Review.Clin Pharmacokinet2026https://conductscience.org/library/papers/41348398PubMed
41313259Development of population pharmacokinetic models of total and free piperacillin in critically ill children and young adults for Monte Carlo simulations and model-informed precision dosing.J Antimicrob Chemother2026https://conductscience.org/library/papers/41313259PubMed

See all 279 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19252334

GET https://conductscience.org/api/papers/v1/19252334/cited_by?page=2